166 related articles for article (PubMed ID: 37489989)
1. Interobserver Variability and Diagnostic Performance in Predicting Malignancy of Pancreatic Intraductal Papillary Mucinous Neoplasm with MRI.
Choi SY; Min JH; Kim JH; Park HJ; Kim YY; Han YE; Bae SH; Lee JH; Choi YH; Moon JE
Radiology; 2023 Jul; 308(1):e222463. PubMed ID: 37489989
[TBL] [Abstract][Full Text] [Related]
2. Determining Malignant Potential of Intraductal Papillary Mucinous Neoplasm of the Pancreas: CT versus MRI by Using Revised 2017 International Consensus Guidelines.
Lee JE; Choi SY; Min JH; Yi BH; Lee MH; Kim SS; Hwang JA; Kim JH
Radiology; 2019 Oct; 293(1):134-143. PubMed ID: 31478800
[TBL] [Abstract][Full Text] [Related]
3. Intraductal papillary mucinous neoplasm of the pancreas: diagnostic performance of the 2017 international consensus guidelines using CT and MRI.
Min JH; Kim YK; Kim SK; Kim H; Ahn S
Eur Radiol; 2021 Jul; 31(7):4774-4784. PubMed ID: 33409798
[TBL] [Abstract][Full Text] [Related]
4. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline.
Hwang JA; Choi SY; Lee JE; Kim SS; Lee S; Moon JY; Heo NH
Eur Radiol; 2020 Jul; 30(7):3711-3722. PubMed ID: 32095876
[TBL] [Abstract][Full Text] [Related]
5. Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT.
Do RK; Katz SS; Gollub MJ; Li J; LaFemina J; Zabor EC; Moskowitz CS; Klimstra DS; Allen PJ
AJR Am J Roentgenol; 2014 Nov; 203(5):973-9. PubMed ID: 25341134
[TBL] [Abstract][Full Text] [Related]
6. Interobserver Variability and Diagnostic Performance of Gadoxetic Acid-enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma.
Min JH; Lee MW; Park HS; Lee DH; Park HJ; Lim S; Choi SY; Lee J; Lee JE; Ha SY; Cha DI; Carriere KC; Ahn JH
Radiology; 2020 Dec; 297(3):573-581. PubMed ID: 32990512
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of magnetic resonance image for malignant intraductal papillary mucinous neoplasms: the importance of size of enhancing mural nodule within cyst.
Hong SB; Lee NK; Kim S; Seo HI; Park YM; Noh BG; Kim DU; Han SY; Kim TU
Jpn J Radiol; 2022 Dec; 40(12):1282-1289. PubMed ID: 35781178
[TBL] [Abstract][Full Text] [Related]
8. Validation of the 2012 International Consensus Guidelines Using Computed Tomography and Magnetic Resonance Imaging: Branch Duct and Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Seo N; Byun JH; Kim JH; Kim HJ; Lee SS; Song KB; Kim SC; Han DJ; Hong SM; Lee MG
Ann Surg; 2016 Mar; 263(3):557-64. PubMed ID: 25822687
[TBL] [Abstract][Full Text] [Related]
9. Abbreviated Magnetic Resonance Imaging With Breath-Hold Three-Dimensional Magnetic Resonance Cholangiopancreatography: Assessment of Malignant Risk of Pancreatic Intraductal Papillary Mucinous Neoplasm.
Yoo J; Min JH; Lee DH; Hur BY; Kim SW; Kim E
J Magn Reson Imaging; 2021 Oct; 54(4):1177-1186. PubMed ID: 33779024
[TBL] [Abstract][Full Text] [Related]
10. Agreement among Magnetic Resonance Imaging/Magnetic Resonance Cholangiopancreatography (MRI-MRCP) and Endoscopic Ultrasound (EUS) in the evaluation of morphological features of Branch Duct Intraductal Papillary Mucinous Neoplasm (BD-IPMN).
Uribarri-Gonzalez L; Keane MG; Pereira SP; Iglesias-García J; Dominguez-Muñoz JE; Lariño-Noia J
Pancreatology; 2018 Mar; 18(2):170-175. PubMed ID: 29338919
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Malignant Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Comparison between Multidetector CT and MR Imaging with MR Cholangiopancreatography.
Kang HJ; Lee JM; Joo I; Hur BY; Jeon JH; Jang JY; Lee K; Ryu JK; Han JK; Choi BI
Radiology; 2016 Apr; 279(1):128-39. PubMed ID: 26517448
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
[No Abstract] [Full Text] [Related]
13. MRI Combined with Magnetic Resonance Cholangiopancreatography for Diagnosis of Benign and Malignant Pancreatic Intraductal Papillary Mucinous Neoplasms.
Liu X; Xu W; Liu Z; Ye J
Curr Med Imaging Rev; 2019; 15(5):504-510. PubMed ID: 32008558
[TBL] [Abstract][Full Text] [Related]
14. Intraductal papillary mucinous neoplasms of the pancreas: evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography.
Kim SH; Lee JM; Lee ES; Baek JH; Kim JH; Han JK; Choi BI
Radiology; 2015 Mar; 274(3):723-33. PubMed ID: 25302831
[TBL] [Abstract][Full Text] [Related]
15. LI-RADS Version 2018 Targetoid Appearances on Gadoxetic Acid-Enhanced MRI: Interobserver Agreement and Diagnostic Performance for the Differentiation of HCC and Non-HCC Malignancy.
Min JH; Lee MW; Park HS; Lee DH; Park HJ; Lee JE; Park SJ; Kim SS; Park SH; Ha SY; Hwang JA; Cha DI; Park B
AJR Am J Roentgenol; 2022 Sep; 219(3):421-432. PubMed ID: 35319906
[No Abstract] [Full Text] [Related]
16. Preoperative CT Classification of the Resectability of Pancreatic Cancer: Interobserver Agreement.
Joo I; Lee JM; Lee ES; Son JY; Lee DH; Ahn SJ; Chang W; Lee SM; Kang HJ; Yang HK
Radiology; 2019 Nov; 293(2):343-349. PubMed ID: 31502935
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic fat content may increase the risk of imaging progression in low-risk branch duct intraductal papillary mucinous neoplasm.
Kashiwagi K; Minami K; Seino T; Hirata K; Iwasaki E; Inoue N; Iwao Y; Kanai T
J Dig Dis; 2019 Oct; 20(10):557-562. PubMed ID: 31322828
[TBL] [Abstract][Full Text] [Related]
18. Threshold of Main Pancreatic Duct Diameter in Identifying Malignant Intraductal Papillary Mucinous Neoplasm by Magnetic Resonance Imaging.
Zhang H; Cao Y; Ren S; Guo K; Zhang Y; Lin T; Wang Y; Chen X; Wang Z
Technol Cancer Res Treat; 2023; 22():15330338231170942. PubMed ID: 37078135
[No Abstract] [Full Text] [Related]
19. Magnetic resonance (MR) for mural nodule detection studying Intraductal papillary mucinous neoplasms (IPMN) of pancreas: Imaging-pathologic correlation.
D'Onofrio M; Tedesco G; Cardobi N; De Robertis R; Sarno A; Capelli P; Martini PT; Giannotti G; Beleù A; Marchegiani G; Gobbo S; Butturini G; Bogdan M; Salvia R; Bassi C
Pancreatology; 2021 Jan; 21(1):180-187. PubMed ID: 33376061
[TBL] [Abstract][Full Text] [Related]
20. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
